A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
מצבים רפואיים
Ovarian Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Beijing Obstetrics and Gynecology Hospital Capital Medical University, Beijing, Beijing Municipality, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
AnYang Tumor Hospital, Anyang, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
The First Hospital of China Medical University, Shenyang, Liaoning, China
Shandong Cancer Hospital, Jinan, Shandong, China
Tianjin Medical University Cancer Institute &Hospital, Tianjin, Tianjin Municipality, China
Yunnan Cancer Hospital, Kunming, Yunnan, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
מובילי המחקר
lingying wu
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences